Mary L. Smith
Director at Ptc Therapeutics, Inc. (PTCT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 13SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 10,00021,813 held (−31%) | $90.00 | $900K | -34.2% |
| Jul 13SEC | PTCTPtc Therapeutics, Inc. | Sell Plan | 5,83421,813 held (−21%) | $90.00 | $525K | -34.2% |
- Sell
Director Mary L. Smith sold $900K of PTCT at $90.00 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Mary L. Smith sold $525K of PTCT at $90.00 — pre-scheduled 10b5-1 plan sale.